Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
No open-market purchases or sales by Processa Pharmaceuticals, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 20 | 18 | −2 |
| Shares | 1.39M | 1.13M | −255.3K (−18.4%) |
| Value | $349.8K | $376.5K | +$26.7K (+7.6%) |
New holders (4)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Spinnaker Trust | 76,865 | $25.7K | 0.00% |
| Two Sigma Investments, LP | 18,677 | $6.25K | 0.00% |
| McCollum Christoferson Group LLC | 12,500 | $4.18K | 0.00% |
| Courier Capital LLC | 12,000 | $4.01K | 0.00% |
Sold out (6)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Walleye Capital LLC | 419,277 | $106.9K |
| Millennium Management LLC | 25,930 | $6.61K |
| Mirador Capital Partners LP | 19,516 | $4.88K |
| Virtu Financial LLC | 11,617 | $3.00K |
| JPMorgan Chase & Co | 20 | $5 |
| Macroview Investment Management LLC | 12 | $3 |